VetStem receives immunotherapy license from human health firmJuly 15, 2019Biopharmaceutical animal health company VetStem has partnered with Calidi Biotherapeutics, a clinical‐stage biotechnology company specializing in the stem cell-based delivery of oncolytic virus-based immunotherapies for cancer.
SPONSORED CONTENTOne dose protects for 12 months.One ProHeart® 12 (moxidectin) injection puts compliance in your control. + Get started